Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarction-Reference-Cited by-同舟云学术

Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarction

Published:1997-08 Issue:2 Volume:134 Page:213-219
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Vanderschueren Steven,Dens Jo,Kerdsinchai Pitsanu,Desmet Walter,Vrolix Mathias,De Man Filip,Van den Heuvel Paul,Hermans Luc,Collen Désiré,Van de Werf Frans

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Rationale for bolus t-PA therapy to improve efficacy and safety;Agnelli;Chest,1990

2. Efficacy of 100 mg of double-bolus alteplase in achieving complete perfusion in the treatment of acute myocardial infarction;Purvis;J Am Coll Cardiol,1994

3. Novel and innovative dosing regimens in thrombolytic therapy for acute myocardial infarction;Purvis;J Thromb Thrombolysis,1995

4. Achieving optimal reperfusion without adjunctive antithrombotic therapy: novel thrombolytic dosing strategies;Becker;J Thromb Thrombolysis,1995

5. Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential?;Collen;Blood,1994

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Split intein-mediated backbone cyclization enhances the stability and activity of staphylokinase, a potent fibrin-selective plasminogen activator;International Journal of Biological Macromolecules;2024-08

2. <i>Aspergillus tabacinus</i> as a producer of antithrombotic proteases;Микология и фитопатология;2024-02-15

3. Efficacy evaluation of r-SaK in a novel canine acute cerebral vessel thromboembolism model;2023-07-28

4. Experience of using a Russian alteplase product as thrombolytic therapy in patients with ischemic stroke in routine practice;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023

5. Hidden Potential of Highly Efficient and Widely Accessible Thrombolytic Staphylokinase;Stroke;2022-10